Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial

被引:22
|
作者
Foulds, Jonathan [1 ]
Cobb, Caroline O. [2 ,3 ]
Yen, Miao-Shan [2 ,4 ]
Veldheer, Susan [1 ,2 ]
Brosnan, Phoebe [3 ]
Yingst, Jessica [1 ]
Hrabovsky, Shari [1 ]
Lopez, Alexa A. [5 ]
Allen, Sophia, I [1 ]
Bullen, Christopher [6 ]
Wang, Xi [1 ]
Sciamanna, Chris [1 ]
Hammett, Erin [1 ]
Hummer, Breianna L. [1 ]
Lester, Courtney [1 ]
Richie, John P. [1 ]
Chowdhury, Nadia [2 ]
Graham, Jacob T. [2 ]
Kang, Le [2 ]
Sun, Shumei [2 ]
Eissenberg, Thomas [2 ,3 ]
机构
[1] Penn State Coll Med, Ctr Res Tobacco & Hlth, Hershey, PA USA
[2] Virginia Commonwealth Univ, Ctr Study Tobacco Prod, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA
[4] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA
[5] Univ Wisconsin, Coll Nursing, Milwaukee, WI 53201 USA
[6] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand
基金
美国国家卫生研究院;
关键词
LIQUID NICOTINE;
D O I
10.1093/ntr/ntab247
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction The extent to which use of electronic nicotine delivery systems (ENDS) for smoking reduction leads to cigarette abstinence in smokers with no plans to quit smoking is unclear. This exploratory analysis examined the effects of ENDS delivering different amounts of nicotine on cigarette abstinence up to 24-week follow-up, in comparison to placebo or a behavioral substitute. Methods This four-arm parallel-group, randomized, placebo-controlled trial took place at two academic medical centers in the United States (Penn State Hershey and Virginia Commonwealth University). Participants were current adult smokers (N = 520) interested in reducing but not planning to quit. They received brief advice and were randomized to one of four 24-week conditions, receiving either an eGo-style ENDS paired with 0, 8, or 36 mg/ml nicotine liquid (double-blind) or a cigarette-shaped tube, as a cigarette substitute (CS). Self-reported daily cigarette consumption and exhaled carbon monoxide (CO) were measured at all study visits. Outcomes included intent-to-treat, self-reported 7-day cigarette abstinence, biochemically confirmed by exhaled CO at 24 weeks after randomization. Results At 24 weeks, significantly more participants in the 36 mg/ml condition (14/130, 10.8%) than in the 0 mg/ml condition (1/130, 0.8%) and the CS condition (4/130, 3.1%) were abstinent (relative risk = 14 [95% CI = 1.9-104.9] and 3.5 [95% CI = 1.2-10.4], respectively). The abstinence rate in the 8 mg/ml condition was 4.6% (6/130). Conclusions When smokers seeking to reduce smoking tried ENDS, few quit smoking in the short term. However, if smokers continued to use an ENDS with cigarette-like nicotine delivery, a greater proportion completely switched to ENDS, as compared with placebo or a cigarette substitute. Implications The extent to which use of electronic nicotine delivery systems (ENDS) for smoking reduction leads to cigarette abstinence in smokers with no plans to quit smoking was unclear. This randomized trial found that ENDS with nicotine delivery approaching that of a cigarette are more effective in helping ambivalent smokers to quit cigarette smoking.
引用
收藏
页码:955 / 961
页数:7
相关论文
共 50 条
  • [1] Effects of electronic cigarettes on smoking cessation in smokers with no plans to quit: A randomized placebo-controlled trial
    Foulds, Jonathan
    Cobb, Caroline
    Yen, Miao-Shan
    Veldheer, Susan
    Brosnan, Phoebe
    Yingst, Jessica
    Hrabovsky, Shari
    Lopez, Alexa
    Allen, Sophia
    Bullen, Christopher
    Sciamanna, Chris
    Eissenberg, Thomas
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2021, 28 (SUPPL 1) : S186 - S186
  • [2] Are electronic nicotine delivery systems (ENDs) helping cigarette smokers quit?-Current evidence
    Patil, Shankargouda
    Arakeri, Gururaj
    Patil, Shekar
    Baeshen, Hosam Ali
    Raj, Thirumal
    Sarode, Sachin C.
    Sarode, Gargi S.
    Awan, Kamran H.
    Gomez, Ricardo
    Brennan, Peter A.
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2020, 49 (03) : 181 - 189
  • [3] Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial
    Hughes, John R.
    Rennard, Stephen I.
    Fingar, James R.
    Talbot, Sandy K.
    Callas, Peter W.
    Fagerstrom, Karl O.
    [J]. NICOTINE & TOBACCO RESEARCH, 2011, 13 (10) : 955 - 964
  • [4] A Randomized placebo-controlled trial of a conjugate nicotine vaccine (NicVAX®) in smokers who want to quit:: 12 month results
    Rennard, Stephen I.
    Jorenby, Douglas E.
    Gonzales, David
    Rigotti, Nancy A.
    de Vos, Arjen
    Bortey, Enoch B.
    Akhavain, Roxanne
    Hatsukami, Dorothy K.
    [J]. CIRCULATION, 2007, 116 (16) : 844 - 844
  • [5] Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: A randomized trial
    Etter, JF
    Laszlo, E
    Zellweger, JP
    Perrot, C
    Perneger, TV
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 487 - 495
  • [6] Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial
    Stapleton, John A.
    Sutherland, Gay
    [J]. ADDICTION, 2011, 106 (04) : 824 - 832
  • [7] Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study
    Takahashi, Hidehiko
    Fujimura, Yota
    Hayashi, Mika
    Takano, Harumasa
    Kato, Motoichiro
    Okubo, Yoshiro
    Kanno, Iwao
    Ito, Hiroshi
    Suhara, Tetsuya
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (03): : 413 - 417
  • [8] A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers
    Glover, Elbert D.
    Laflin, Molly T.
    Schuh, Kory J.
    Schuh, Leslie M.
    Nides, Mitch
    Christen, Arden G.
    Glover, Penny N.
    Strnad, Julia V.
    [J]. ADDICTION, 2007, 102 (05) : 795 - 802
  • [9] A Pilot Randomized, Placebo-Controlled, Double-Blind Trial of a Multistep Herbal Program for Assisting Smokers to Quit
    James, Gary D.
    Britton, Geraldine R.
    Sobczak, Janet
    Rhodes-Keefe, Joyce
    Sprague, Lori
    Gueldner, Sarah H.
    [J]. JOURNAL OF ADDICTIONS NURSING, 2012, 23 (04) : 231 - 240
  • [10] RCT Abstract - Varenicline and nicotine replacement therapy for smokers admitted to hospitals: a randomized, placebo-controlled trial
    Abramson, Michael J.
    Weeks, Greg
    Gobarani, Rukshar
    Bonevski, Billie
    Webb, Ashley
    Thomas, Dennis
    Paul, Eldho
    Sarwar, Rehan
    Smith, Brian
    Perinpanathan, Sharmilla
    Kirsa, Sue
    Parkinson, Jacqueline
    Meanger, Darshana
    Coward, Lisa
    Rofe, Olivia
    Lee, Paula
    Van Den Bosch, Denise
    George, Johnson
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62